CBAN vs NRIM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

CBAN

63.2
AI Score
VS
CBAN Wins

NRIM

62.9
AI Score

Investment Advisor Scores

CBAN

63score
Recommendation
BUY

NRIM

63score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CBAN NRIM Winner
Forward P/E 11.0011 12.7714 CBAN
PEG Ratio 2.1066 0 Tie
Revenue Growth 25.3% 8.3% CBAN
Earnings Growth 11.5% 30.8% NRIM
Tradestie Score 63.2/100 62.9/100 CBAN
Profit Margin 22.5% 31.8% NRIM
Beta 1.00 1.00 Tie
AI Recommendation BUY STRONG BUY NRIM

Relative Price Performance (Last 90 Days)

CBAN 1M: -2.5% · 3M: +3.3% NRIM 1M: -2.9% · 3M: +2.5%

Current Technical Phase

CBAN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.8% over 20 days), RSI 51

RSI (14): 50.5 · Price: $21.46

NRIM

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope 0.2%) with fading momentum, RSI 50

RSI (14): 50.0 · Price: $26.16

Fundamentals Snapshot

Metric CBAN NRIM
Market Cap
Forward P/E 9.6 9.5
Trailing P/E 12.9 8.6
Revenue (TTM)
Revenue Growth 0.3% 0.1%
Gross Margin 1.0% 1.0%
Operating Margin 0.4% 0.4%
EPS 1.67 3.04
Dividend Yield 0.02% 0.01%

Frequently Asked Questions

Based on our detailed analysis, CBAN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.